Basilea Pharmaceutica AG (BPMUF)
USD 52.83
(0.0%)
USD 52.83
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 14.24 Million | 7.05 Million | -32.02 Million | -54.13 Million | -63.83 Million | -79.21 Million |
| Net Income | 10.45 Million | 12.14 Million | -6.83 Million | -14.72 Million | -22.42 Million | -31.35 Million |
| Depreciation & Amortization | 1.57 Million | 1.09 Million | 754 Thousand | 1.19 Million | 1.63 Million | 1.85 Million |
| Deferred income taxes | 1.23 Million | 1.13 Million | 1.94 Million | -10.08 Million | -4.61 Million | - |
| Stock-based compensation | 4.76 Million | 3.59 Million | 4.32 Million | 3.52 Million | 3.04 Million | 6.3 Million |
| Change in working capital | -5.22 Million | -11.38 Million | -33.3 Million | -35.4 Million | -42.24 Million | -56.71 Million |
| Other non-cash items | 1.44 Million | 456 Thousand | 1.09 Million | 1.35 Million | 758 Thousand | 27.81 Million |
| Investing Cash Flow | -1.03 Million | 91.64 Million | 3.57 Million | -34.96 Million | -404 Thousand | 59.39 Million |
| Investments in PPE | -1.03 Million | -3.3 Million | -860 Thousand | -2.26 Million | -404 Thousand | -609 Thousand |
| Acquisitions | - | - | -1.6 Million | 442 Thousand | 110 Thousand | - |
| Investment purchases | - | - | -35 Million | -81.02 Million | -50 Million | - |
| Sales/Maturities of investments | - | 94.95 Million | 41.03 Million | 48.32 Million | 50 Million | 60 Million |
| Other Investing Activities | -221 Thousand | 1000.00 | 15 Thousand | -442 Thousand | -110 Thousand | 59.81 Million |
| Financing Cash Flow | -57.3 Million | -45.24 Million | 16.64 Million | 45.06 Million | 1.3 Million | -5.98 Million |
| Debt repayment | -59.31 Million | -123.54 Million | -23.21 Million | -53.63 Million | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | -381 Thousand | - | -4.25 Million | - | - | -6.23 Million |
| Common Stock Issuance | 2.39 Million | 4.42 Million | 44.1 Million | 4.8 Million | 1.3 Million | 249 Thousand |
| Other Financing Activities | 2 Million | 73.87 Million | 23.21 Million | 93.89 Million | 1.3 Million | 249 Thousand |
| Accounts receivables | 3.45 Million | 2.58 Million | -32.06 Million | -4.12 Million | 6.45 Million | -19.89 Million |
| Accounts payables | 5.65 Million | -10.42 Million | -2.53 Million | 6.39 Million | 378 Thousand | 2.05 Million |
| Inventory | -2.16 Million | -1.46 Million | -1.59 Million | -2.61 Million | -4.14 Million | 741 Thousand |
| Other working capital | -12.16 Million | -2.07 Million | 2.88 Million | -35.05 Million | -44.93 Million | -39.61 Million |
| Cash at beginning of period | 108.56 Million | 54.95 Million | 66.25 Million | 111.04 Million | 173.9 Million | 50.12 Million |
| Cash at end of period | 64.32 Million | 108.56 Million | 54.95 Million | 66.25 Million | 111.04 Million | 38.3 Million |
| Capital Expenditure | -1.03 Million | -3.3 Million | -860 Thousand | -2.26 Million | -404 Thousand | -609 Thousand |
| Effect of forex changes on cash | -151 Thousand | 155 Thousand | 501 Thousand | -758 Thousand | 67 Thousand | -1.01 Million |
| Net cash flow / Change in cash | -44.24 Million | 53.61 Million | -11.3 Million | -44.78 Million | -62.86 Million | -11.81 Million |
| Free Cash Flow | 13.21 Million | 3.75 Million | -32.88 Million | -56.39 Million | -64.24 Million | -79.81 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 10.36 Million | 10.36 Million | 10.45 Million | -21.38 Million | -10.69 Million | 31.84 Million |
| Depreciation & Amortization | 598.5 Thousand | 598.5 Thousand | 1.57 Million | 1.72 Million | 762 Thousand | 1.75 Million |
| Deferred income taxes | -13.42 Million | - | 1.23 Million | 2.63 Million | - | -5.02 Million |
| Stock-based compensation | 1.25 Million | 1.25 Million | 4.76 Million | 1.24 Million | 1.24 Million | 1.13 Million |
| Change in working capital | 576 Thousand | 576 Thousand | -5.22 Million | 9.17 Million | 3.94 Million | -13.49 Million |
| Other non-cash items | -3.83 Million | -3.83 Million | 1.44 Million | -1.01 Million | 929 Thousand | 5.66 Million |
| Investing Cash Flow | 130.5 Thousand | 130.5 Thousand | -1.03 Million | -645 Thousand | -322.5 Thousand | -389 Thousand |
| Investments in PPE | -233.5 Thousand | -233.5 Thousand | -1.03 Million | -645 Thousand | -249.5 Thousand | -389 Thousand |
| Acquisitions | 781 Thousand | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | 364 Thousand | 364 Thousand | -221 Thousand | -73 Thousand | -73 Thousand | -37.5 Thousand |
| Financing Cash Flow | -6.57 Million | -6.57 Million | -57.3 Million | -40.22 Million | -20.11 Million | -17.08 Million |
| Debt repayment | -15.6 Million | - | -59.31 Million | -18.42 Million | - | -18.42 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | -381 Thousand | -384 Thousand | - | -88 Thousand |
| Common Stock Issuance | 2.31 Million | - | 2.39 Million | 1.04 Million | - | 1.43 Million |
| Other Financing Activities | -6.57 Million | -6.57 Million | 2 Million | -20.11 Million | -20.11 Million | -8.54 Million |
| Accounts receivables | -87.5 Thousand | -87.5 Thousand | 3.45 Million | 6.19 Million | 5.87 Million | -2.74 Million |
| Accounts payables | 5.62 Million | - | 5.65 Million | 1.9 Million | - | 3.75 Million |
| Inventory | -2.48 Million | -2.48 Million | -2.16 Million | -772 Thousand | -386 Thousand | -1.39 Million |
| Other working capital | 3.14 Million | 3.14 Million | -12.16 Million | 1.84 Million | -1.54 Million | -13.1 Million |
| Cash at beginning of period | 12.48 Million | - | 108.56 Million | 90.94 Million | - | 36.56 Million |
| Cash at end of period | 69.47 Million | 2.57 Million | 64.32 Million | 12.48 Million | -24.31 Million | 90.94 Million |
| Capital Expenditure | -233.5 Thousand | -233.5 Thousand | -1.03 Million | -645 Thousand | -249.5 Thousand | -389 Thousand |
| Effect of forex changes on cash | 54.5 Thousand | 54.5 Thousand | -151 Thousand | -69.5 Thousand | -69.5 Thousand | -6000.00 |
| Net cash flow / Change in cash | 56.98 Million | 2.57 Million | -44.24 Million | -78.45 Million | -24.31 Million | 54.38 Million |
| Free Cash Flow | 8.72 Million | 8.72 Million | 13.21 Million | -8.26 Million | -4.05 Million | 21.47 Million |
0N0B
ALNLF
2789
0804
AVB
9267